ArticleJournal of immunotherapy and precision oncology2025
Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma.
Brenda Chahla et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it